AB Volvo: The Foundation Assar Gabrielsson Prize recipients 2025 awarded
The Assar Gabrielsson Foundation, established in 1962 by Volvo co-founder Assar Gabrielsson, has announced its 2025 prize recipients. Marcus Borenäs won the basic science research category for his work on malignant neuroblastomas in children, while Elizabeth Schepke received the clinical research award for her studies on DNA methylation in pediatric brain tumors. Each winner receives SEK 100,000 in research grants, administered by the Sahlgrenska Academy at the University of Gothenburg. The foundation primarily supports promising early-stage cancer research projects that have not yet secured major funding.
La Fondazione Assar Gabrielsson, istituita nel 1962 dal cofondatore di Volvo Assar Gabrielsson, ha annunciato i vincitori dei premi 2025. Marcus Borenäs ha vinto nella categoria ricerca di base per il suo lavoro sui neuroblastomi maligni nei bambini, mentre Elizabeth Schepke ha ricevuto il premio per la ricerca clinica per i suoi studi sulla metilazione del DNA nei tumori cerebrali pediatrici. Ciascun vincitore riceve una sovvenzione di ricerca di 100.000 SEK, gestita dall'Accademia Sahlgrenska dell'Università di Göteborg. La fondazione sostiene principalmente progetti promettenti di ricerca sul cancro in fase iniziale che non hanno ancora ottenuto finanziamenti importanti.
La Fundación Assar Gabrielsson, establecida en 1962 por el cofundador de Volvo Assar Gabrielsson, ha anunciado los ganadores de sus premios 2025. Marcus Borenäs ganó en la categoría de investigación básica por su trabajo sobre neuroblastomas malignos en niños, mientras que Elizabeth Schepke recibió el premio a la investigación clínica por sus estudios sobre la metilación del ADN en tumores cerebrales pediátricos. Cada ganador recibe una subvención de investigación de 100,000 SEK, administrada por la Academia Sahlgrenska de la Universidad de Gotemburgo. La fundación apoya principalmente proyectos prometedores de investigación temprana sobre el cáncer que aún no han obtenido financiación importante.
아사르 가브리엘손 재단은 1962년 볼보 공동 창립자 아사르 가브리엘손에 의해 설립되었으며, 2025년 수상자를 발표했습니다. 마커스 보레네스는 소아 악성 신경아세포종에 관한 기초 과학 연구 부문에서 수상했으며, 엘리자베스 셰프케는 소아 뇌종양의 DNA 메틸화 연구로 임상 연구상을 받았습니다. 각 수상자는 예테보리 대학교 살그렌스카 아카데미가 관리하는 SEK 100,000의 연구 지원금을 받습니다. 이 재단은 주로 아직 주요 자금을 확보하지 못한 초기 단계의 유망한 암 연구 프로젝트를 지원합니다.
La Fondation Assar Gabrielsson, créée en 1962 par le cofondateur de Volvo Assar Gabrielsson, a annoncé ses lauréats pour 2025. Marcus Borenäs a remporté la catégorie recherche fondamentale pour ses travaux sur les neuroblastomes malins chez l’enfant, tandis que Elizabeth Schepke a reçu le prix de la recherche clinique pour ses études sur la méthylation de l’ADN dans les tumeurs cérébrales pédiatriques. Chaque lauréat reçoit une subvention de recherche de 100 000 SEK, administrée par l’Académie Sahlgrenska de l’Université de Göteborg. La fondation soutient principalement des projets prometteurs de recherche sur le cancer en phase précoce qui n’ont pas encore obtenu de financements majeurs.
Die Assar Gabrielsson Stiftung, gegründet 1962 vom Volvo-Mitbegründer Assar Gabrielsson, hat ihre Preisträger für 2025 bekanntgegeben. Marcus Borenäs gewann die Kategorie Grundlagenforschung für seine Arbeit zu malignen Neuroblastomen bei Kindern, während Elizabeth Schepke den Preis für klinische Forschung für ihre Studien zur DNA-Methylierung bei pädiatrischen Hirntumoren erhielt. Jeder Gewinner erhält einen Forschungszuschuss von 100.000 SEK, verwaltet von der Sahlgrenska Akademie der Universität Göteborg. Die Stiftung unterstützt vor allem vielversprechende Krebsforschungsprojekte in der Frühphase, die noch keine größeren Fördermittel erhalten haben.
- None.
- None.
"Marcus Borenäs is awarded the prize in the category of basic science research for advanced research on malignant neuroblastomas in children. The studies provide new knowledge about ALK signaling in different types of neuroblastoma. Neuroblastoma is a form of cancer that develops in what is known as the sympathetic nervous system. The results can be of great benefit for the development of better treatment for patients with this type of cancer," says Eva Forssell-Aronsson, professor at the University of
"Elizabeth Schepke receives the prize in the clinical research category for research on the importance of so-called DNA methylation in brain tumours in children. The studies provide new knowledge about how these tumours can be better classified, so that the most appropriate treatment can be chosen," says Professor Eva Forssell-Aronsson.
Assar Gabrielsson was one of the founders of Volvo. In accordance with his wishes, a fund was established for clinical research of cancer diseases. The fund has existed since 1962. It primarily supports research projects that are considered promising but have not yet reached the weight that provides funding from major research funds.
May 15, 2025
Journalists wanting further information, please contact:
Eva Forssell-Aronsson
Executive Member of the Assar Gabrielsson Foundation
+46 70 372 26 26
For more information, please visit volvogroup.com
For frequent updates, follow us on LinkedIn
The Volvo Group drives prosperity through transport and infrastructure solutions, offering trucks, buses, construction equipment, power solutions for marine and industrial applications, financing and services that increase our customers' uptime and productivity. Founded in 1927, the Volvo Group is committed to shaping the future landscape of sustainable transport and infrastructure solutions. The Volvo Group is headquartered in
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Press Release - The Foundation Assar Gabrielsson Prize recipients 2025 awarded | |
https://news.cision.com/ab-volvo/i/assargfoundation-1860x1050,c3409593 | AssarGFoundation 1860X1050 |
View original content:https://www.prnewswire.com/news-releases/ab-volvo-the-foundation-assar-gabrielsson-prize-recipients-2025-awarded-302456416.html
SOURCE AB Volvo